Boehringer Ingelheim Corporation Plans To Cut Up To 600 Jobs
Emergency Use Of Tekmira Pharmaceuticals Corporation (TKMR)'s Ebola Drug Cleared By FDA, Health Canada
Pfizer (PFE) Approaches Actavis (ACT) To Gauge Interest In Deal: Sources
Allergan Inc. (AGN) Rejected Actavis (ACT), Continues Courting Salix Pharmaceuticals, Ltd. (SLXP)
Allergan Inc. (AGN) Must Turn Over Strategic Documents In Takeover Fight: Judge
AstraZeneca PLC (AZN), Shire Shares Plummet On New U.S. Rules To Curb Tax-Inversion Deals
Swiss Biotech Firm Molecular Partners AG Plans $134 Million IPO
Viropro Inc. (VPRO) Subsidiary Alpha Biologics Sdn Bhd (ABSB)'s Assets Have Been Seized By A Bank In Malaysia
Departure Of Ariad Pharmaceuticals, Inc. (ARIA) Director Sparks Speculation That CEO Berger's Days Are Numbered
Amgen (AMGN) Asks FDA For Biologics License For Breakthrough Cancer Drug Blinatumomab
Novartis AG (NVS) Studies Muscle Atrophy By Sending Mice Into Space
Analysts: New Inversion Rules Won't Scuttle Mylan Inc. (MYL), Medtronic, Inc. (MDT) Deals
Wall Street Overreacting To Inversion Proposals, Says ISI Group
Par Pharmaceutical, Inc. To Pay $100 Million To Settle Suit Over Generic Heartburn Drug
Merus Labs International Inc. CEO Steps Down: Interim Chief Named
Regeneron Pharmaceuticals, Inc. (REGN) R&D Chief Reveals Allergy Drug May Be Darling Of Its Pipeline
Merck KGaA (MKGAF.PK) To Pay $17 Billion For St. Louis-Based Sigma-Aldrich Corporation (SIAL)
GlaxoSmithKline (GSK) Deals With Fallout From Polio Virus Spill
See All News >